Selective drug resistant human osteosarcoma cell lines

Clinical Orthopaedics and Related Research

Volumn 383, Issue , 2001, Pages 259-267

  Burns, Bennett S ^a   Edin, Matthew L ^a   Lester, Gayle E ^a   Tuttle, Harrison G ^a   Wall, Monroe E ^b   Wani, Mansukh C ^b   Bos, Gary D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; GLYCOPROTEIN P; PACLITAXEL; TOPOTECAN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035146975     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200102000-00030     Document Type: Article

References (38)

1. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities
2. Interaction of tubulin and cellular microtubules with Taxotere (RP 56976), a new semisynthetic analog of Taxol
3. Preclinical anti-tumor activity and pharmacokinetics of irinotecan (CPT-11) in tumor-bearing mice
4. Topoisomerase I inhibitors. An overview of the camptothecin analogs
5. Differential effects of P glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters
6. P-glucoprotein expression: Critical determinant in the response to osteosarcoma chemotherapy
7. Structure-activity relation in camptothecin antitumor drugs: Why a detailed molecular characterisation of their lactone and carboxylate forms by Raman and SERS spectroscopies?
8. Taxotere and Taxol in breast cancer therapy: Present status and future prospects
9. Phase I trial of Q4DTaxol regimen in pediatric patients with recurrent solid tumors
10. Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro
11. An assay to measure adriamycin binding in osteosarcoma cells
12. A phase II trial of paclitaxel in the treatment of recurrent or metastatic soft tissue or bone sarcomas
13. Experience with multiagent chemotherapy or osteosarcoma
14. Phase II trial of Taxol, an active drug in the treatment of metastatic breast cancer
15. Taxol: Mechanisms of action and resistance
16. Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors
17. Taxotere in anthracycline-resistant metastatic breast cancer
18. Comparative in vitro cytotoxicity of Taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines
19. Anti-tumor activity of 7-ethyl-10-[4-(1piperidino)-1-piperidino] carbonyl oxycamptothecin: A novel water-soluble derivative of camptothecin, against routine tumors
20. In vitro evaluation of chemosensitizers for clinical reversal of P-glycoprotein-associated Taxol resistance
21. Taxol: An anti-mitotic agent with a new mechanism of action
22. Taxol: A unique anti-neoplastic agent with significant activity in advanced ovarian epithelial neoplasms
23. Phase II study of Taxol in patients with untreated, advanced non-small cell lung cancer
24. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: Exceptional activity against drug-resistant cancer cells
25. Phase II study of Taxol in patients with previously treated osteosarcoma and its variants
26. Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor types
27. Piccart M: Treatment of advanced breast cancer
28. Camptothecins: From bench research to hospital wards
29. Phase I and pharmacodynamic study of Taxol in refractory acute leukemias
30. Taxol: A novel investigational anti-microtubule agent
31. Microtubule changes and cytotoxicity in leukemia cell lines treated with Taxol
32. Taxol stabilizes microtubules in mouse fibroblast cells
33. New colorimetric cytotoxicity assay for anti-cancer drug screening
34. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive murine osteosarcoma cell lines
35. Docetaxel as single-agent therapy in metastatic breast cancer: Clinical efficacy
36. Preclinical activity of Taxotere (RP56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with Taxol and conventional antineoplastic agents
37. Plant antitumor agents. I. The isolation and structure of camptothecins: A novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata
38. Plant antitumor agents. VI. The isolation and structure of Taxol: A novel antileukemic and antitumor agent from Taxus brevifolia